Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-024-06953-x ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Patricia Beer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Small Animal Surgery, Vetsuisse Faculty, University Animal Hospital, University of Zurich, Zurich, Switzerland. pbeer@vetclinics.uzh.ch. Hauptthemen laut MEDLINE: Sarcoma, Fluorescent Dyes, Integrin alphaVbeta3, Surgery, Computer-Assisted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Kennel Club Canine Health Foundation, Forschungskredit (Candoc) of the University of Zurich, Legat Bachofner - Seed Money Experimentelle Chirurgie.
Abstract (Originalsprache)
Purpose
Complete resection is a key prognostic factor for survival in patients with soft tissue sarcoma (STS), in humas and companion animals alike. Fluorescence-guided surgery could improve resection accuracy. As dogs are frequently affected by STS, they serve as a model to test an anti-α v β 3 integrin targeting near-infrared fluorescent (NIRF) dye (Angiostamp TM 800) for fluorescence-guided surgery in STS to evaluate its safety and feasibility in dogs, and if it translates into a clinically relevant benefit compared to the standard of care with regards to completeness of surgery and local recurrence. Furthermore, we aimed to correlate target expression and NIRF-signal intensity.
Methods
Twenty dogs with STS were randomly allocated to either receive Angiostamp™ (NIRF group) or physiologic saline (control group) preoperatively. The researchers were blinded for treatment, and resections were adapted based on the NIRF-signal, if needed. Margin status was histologically determined at the 1 and 3 cm margin. The tumor-to-background ratio was measured in native tissue biopsies and formalin-fixed tissue. The fluorescent area was compared to the corresponding tumor areas as confirmed by histology using the Dice coefficient. Target expression was quantified by immunohistochemistry and correlated to NIRF-signal ratios.
Results
A fluorescent signal was detected in all 10 tumors of the NIRF group, with a tumor-to-background ratio of 7.4 ± 5.8 in native biopsies and 13.5 ± 10.9 in formalin-fixed tissue. In the NIRF group, resection margins were adapted in 5/10 cases, leading to complete resection and preventing R1 in four of these cases. In the NIRF and control group 9/10 and 8/10 resections were R0, with one local recurrence in each group and one sarcoma-related death in the NIRF group. The NIRF-signal correlated with the histologically confirmed tumor area (Dice coefficient 0.75 ± 0.17). Target expression was higher in tumor compared to peritumoral tissue ( p < 0.0003) and showed a moderate correlation with the NIRF-signal ( r = 0.6516, p < 0.0001).
Conclusion
Fluorescence-guided surgery using Angiostamp™ can pinpoint residual disease in the tumor bed and contributes to an improved resection accuracy in canine STS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic for Small Animal Surgery, Vetsuisse Faculty, University Animal Hospital, University of Zurich, Zurich, Switzerland. pbeer@vetclinics.uzh.ch.
- Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
- Clinic for Diagnostic Imaging, University Animal Hospital, Vetsuisse Faculty Zurich, University Zurich, Zurich, Switzerland.
- Division of Radiation Oncology, University Animal Hospital, Vetsuisse Faculty Zurich, University Zurich, Zurich, Switzerland.
- Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Veterinary Pharmacology and Toxicology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Patricia Beer, Paula Grest, Christiane Krudewig, Chris Staudinger, Stefanie Ohlerth, Carla Rohrer Bley, Armin Jarosch, Houria Ech-Cherif, Enni Markkanen, Brian Park, Mirja Christine Nolff
Förderung
- American Kennel Club Canine Health Foundation
- Forschungskredit (Candoc) of the University of Zurich
- Legat Bachofner - Seed Money Experimentelle Chirurgie
- Stiftung für Kleintiere of the Vetsuisse-Fakultät Universität Zürich
- University of Zurich
Zitieren
APA
Beer, P., Grest, P., Krudewig, C., Staudinger, C., Ohlerth, S., Rohrer Bley, C., Jarosch, A., Ech-Cherif, H., Markkanen, E., Park, B., & Nolff, M. C. (2025). Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06953-x
Vancouver
Beer P, Grest P, Krudewig C, Staudinger C, Ohlerth S, Rohrer Bley C, et al. Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06953-x
BibTeX
@article{Beer2025,
author = {Beer, Patricia and Grest, Paula and Krudewig, Christiane and Staudinger, Chris and Ohlerth, Stefanie and Rohrer Bley, Carla and Jarosch, Armin and Ech-Cherif, Houria and Markkanen, Enni and Park, Brian and Nolff, Mirja Christine},
title = {Evaluation of a targeted anti-αvβ3 integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-024-06953-x}
}
EUVIMED